Delivery Order SPE2DB20D2104-SPE2DB23FV20U
- Not listed
- This federal contract award, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Carvedilol ER 20 MG capsules. The $13,542.96 firm fixed-price delivery order has an ultimate completion date of February 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range...
- This federal contract award is for the delivery of Carvedilol ER 80 mg capsules to the Defense Logistics Agency (DLA). The $1,432.79 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 6, 2024. The contract has an ultimate completion date of November 7, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp., a subsidiary of Cencora, Inc., is for the delivery of Carvedilol ER 10 mg capsules. The $1,221.58 firm fixed-price delivery order is not designated with a set-aside and has a completion date of January 30, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of...
- This federal contract award is for the delivery of Carvedilol ER 20 mg capsules to the Defense Logistics Agency (DLA), a component of the Department of Defense. The $9,043.42 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 11, 2021. The contract has an ultimate completion date of August 12, 2021 and does not have any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp, a subsidiary of the...
- This federal contract award is for the delivery of Carvedilol ER 20 mg capsules to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price of $27,708.46 and an ultimate completion date of September 21, 2023. The award was made without any set-aside designation, indicating open competition....
- This federal contract award is for the delivery of Carvedilol ER 40 mg capsules to the Defense Logistics Agency (DLA). The contract, worth $1,098.58, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Carvedilol ER 80 mg capsules, a prescription medication. The $2,392.66 delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen, one of the largest pharmaceutical distribution companies, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $3,090.85 for the supply of Carvedilol ER 10 mg capsules. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical...
- This federal contract award is for the delivery of Carvedilol ER 10 mg capsules to the Defense Logistics Agency (DLA). The $1,329.87 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on November 17, 2022, with a completion date of November 20, 2023. The contract is an Indefinite Delivery Contract (IDC) that serves as a primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,216.95 firm fixed-price delivery order is for the supply of Carvedilol ER 20 mg capsules. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FV20UDelivery Order
This federal contract award is for the delivery of Carvedilol ER 20 mg capsules to the Defense Logistics Agency (DLA). The $3,575.71 firm-fixed-price delivery order, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. Amerisourcebergen Drug Corp also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/6/23 |